Clinton Musil
2020
In 2020, Clinton Musil earned a total compensation of $966.9K as Chief Financial Officer at Catalyst Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $66,490 |
|---|---|
| Option Awards | $696,142 |
| Salary | $197,691 |
| Other | $6,589 |
| Total | $966,912 |
Musil received $696.1K in option awards, accounting for 72% of the total pay in 2020.
Musil also received $66.5K in non-equity incentive plan, $197.7K in salary and $6.6K in other compensation.
Rankings
In 2020, Clinton Musil's compensation ranked 8,777th out of 13,090 executives tracked by ExecPay. In other words, Musil earned more than 32.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,777 out of 13,090 | 33rd |
Division Manufacturing | 3,740 out of 5,618 | 33rd |
Major group Chemicals And Allied Products | 1,511 out of 2,251 | 33rd |
Industry group Drugs | 1,316 out of 1,951 | 33rd |
Industry Pharmaceutical Preparations | 972 out of 1,456 | 33rd |
Source: SEC filing on April 27, 2021.
Musil's colleagues
We found two more compensation records of executives who worked with Clinton Musil at Catalyst Biosciences in 2020.